Nanotechnology Advances in the Detection and Treatment of Lymphoid Malignancies
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25179253 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Francesco Maria Adamo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, Institute of Hematology and Center for Hemato-Oncology Research (CREO), University of Perugia, Santa Maria della …. Hauptthemen laut MEDLINE: Nanotechnology, Nanoparticles. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, European Union - FSE-REACT-EU, PON Research and Innovation 2014-2020, University of Perugia "Fondo Ricerca di Ateneo.
Abstract (Originalsprache)
Lymphoid malignancies are complex diseases with distinct biological behaviors, clinical presentations, and treatment responses. Ongoing research and advancements in biotechnology enhance the understanding and management of these malignancies, moving towards more personalized approaches for diagnosis and treatment. Nanotechnology has emerged as a promising tool to improve some limitations of conventional diagnostics as well as treatment strategies for lymphoid malignancies. Nanoparticles (NPs) offer unique advantages such as enhanced multimodal detection, drug delivery, and targeted therapy capabilities, with the potential to improve precision medicine and patient outcomes. Here, we comprehensively examine the current landscape of nanoconstructs applied in the management of lymphoid disease. Through a comprehensive analysis of preclinical studies, we highlight the translational potential of NPs in revolutionizing the field of hematological malignancies, with a specific focus on lymphoid neoplasms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine and Surgery, Institute of Hematology and Center for Hemato-Oncology Research (CREO), University of Perugia, Santa Maria della Misericordia Hospital, 06132 Perugia, Italy.
- Department of Medicine and Surgery, Biosciences and Medical Embryology Section, University of Perugia, 06132 Perugia, Italy.
ORCID-Profile: Filomena De Falco, Paolo Sportoletti
Förderung
- Italian Association for Cancer Research
- European Union - FSE-REACT-EU, PON Research and Innovation 2014-2020
- University of Perugia "Fondo Ricerca di Ateneo
- Associazione Italiana per la Ricerca sul Cancro (AIRC)
- FIRC-AIRC
- European Union-FSE-REACT-EU, PON Research and Innovation 2014–2020
- University of Perugia “Fondo Ricerca di Ateneo, edizione 2021”
Zitieren
APA
Adamo, F. M., De Falco, F., Dorillo, E., Sorcini, D., Stella, A., Esposito, A., Arcaleni, R., Rosati, E., & Sportoletti, P. (2024). Nanotechnology Advances in the Detection and Treatment of Lymphoid Malignancies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179253
Vancouver
Adamo FM, De Falco F, Dorillo E, Sorcini D, Stella A, Esposito A, et al. Nanotechnology Advances in the Detection and Treatment of Lymphoid Malignancies. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179253
BibTeX
@article{Adamo2024,
author = {Adamo, Francesco Maria and De Falco, Filomena and Dorillo, Erica and Sorcini, Daniele and Stella, Arianna and Esposito, Angela and Arcaleni, Roberta and Rosati, Emanuela and Sportoletti, Paolo},
title = {Nanotechnology Advances in the Detection and Treatment of Lymphoid Malignancies},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25179253}
}
EUVIMED